diminazene has been researched along with Cardiovascular Stroke in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, W; Liu, J; Ma, Y; Xia, L; Yu, S; Zhai, M; Zhang, L; Zhu, H | 1 |
| Chen, J; Cui, L; Liu, Q; Ma, R; Sang, H; Shan, L; Yuan, J; Zhang, S | 1 |
| Castardeli, C; Forechi, L; Mill, JG; Pimentel, EB; Sartório, CL | 1 |
| Badae, NM; El Naggar, AS; El Sayed, SM | 1 |
| Cole-Jeffrey, CT; Espejo, A; Hanna, M; Katovich, MJ; Pepine, CJ; Qi, Y; Raizada, MK; Shenoy, V; Song, C; Zhang, J | 1 |
1 review(s) available for diminazene and Cardiovascular Stroke
| Article | Year |
|---|---|
The role of SARS-CoV-2 target ACE2 in cardiovascular diseases.
Topics: Angiotensin-Converting Enzyme 2; Animals; Arrhythmias, Cardiac; Cardiovascular Diseases; COVID-19; COVID-19 Drug Treatment; Diminazene; Heart Failure; Humans; Hypertension; Myocardial Infarction; Recombinant Proteins | 2021 |
4 other study(ies) available for diminazene and Cardiovascular Stroke
| Article | Year |
|---|---|
Protective effect of diminazene attenuates myocardial infarction in rats via increased inflammation and ACE2 activity.
Topics: Angiotensin-Converting Enzyme 2; Animals; Biomarkers; Cardiotonic Agents; Creatine Kinase; Diminazene; Disease Models, Animal; Enzyme Activation; Inflammation; Inflammation Mediators; Lactate Dehydrogenases; Myocardial Infarction; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Rats | 2017 |
The ACE 2 activator diminazene aceturate (DIZE) improves left ventricular diastolic dysfunction following myocardial infarction in rats.
Topics: Angiotensin-Converting Enzyme 2; Animals; Cardiomegaly; Collagen; Diastole; Diminazene; Enzyme Activators; Hemodynamics; Male; Myocardial Infarction; Myocytes, Cardiac; Peptidyl-Dipeptidase A; Rats, Wistar; Ventricular Dysfunction; Ventricular Function | 2018 |
Is the cardioprotective effect of the ACE2 activator diminazene aceturate more potent than the ACE inhibitor enalapril on acute myocardial infarction in rats?
Topics: Acute Disease; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiotonic Agents; Diminazene; Enalapril; Enzyme Activation; Heart Ventricles; Hypertrophy, Right Ventricular; Male; Myocardial Infarction; Peptidyl-Dipeptidase A; Rats; Rats, Wistar | 2019 |
Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology.
Topics: Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Diminazene; Heart; Hemodynamics; Macrophages; Myocardial Infarction; Myocardial Ischemia; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Stem Cells | 2013 |